I’M Iga Antibody Test Results

TruStrip RDT Beta-Lactam and Tetracyclines rapid test strips, results is 2-10 mins, 50 strips/pk

DE-100260-RDT 1 pk Ask for price

Iga Antibody Laboratories manufactures the i’m iga antibody test results reagents distributed by Genprice. The I’M Iga Antibody Test Results reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact iga antibody. Other I’M products are available in stock. Specificity: I’M Category: Iga Group: Antibody Test

TruStrip RDT Melamine rapid test strips, results is 2-10 mins, 50 cards/pk

1 pk Ask for price

TruStrip RDT Lincomycin rapid test strips, results is 2-10 mins, 50 strips/pk

1 pk Ask for price

TruStrip RDT Kanamycin rapid test strips, results is 2-10 mins, 50 strips/pk

1 pk Ask for price

True Blue

5.0mg
EUR 595

True Blue

10mg Ask for price
Description: True Blue

True Blue

1g Ask for price
Description: True Blue

True Blue

1mg Ask for price
Description: True Blue

Antibody Test information

TruStrip RDT Sulfonamides residues (SAs) rapid test strips, results is 2-10 mins, 50 strips/pk

DE-100090-RDT 1 pk
EUR 781.2

TruStrip RDT Beta-Lactam and Tetracyclines rapid test strips, results is 2-10 mins, 50 strips/pk

DE-100260-RDT 1 pk Ask for price

TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk

RV-501200-RDT 1 pk Ask for price

TruStrip RDT Humanized Ebola IgG (humanized IgGs expressed in tobacco or other plants) rapid test (results in 2-10 min), 25 cassettes/pk

AE-320880-RDT-25 1 pk
EUR 351.6

Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores

BR20838 row: 13; column: 16; cores: 208; cases: 118
EUR 474
Description: Multiple organs tumor tissue microarray, containing 80 cases of breast invasive carcinoma of no special type, 10 cancer adjacent breast tissue, duplicate cores per case, 4 ovary serous adenocarcinoma, 4 uterus endometrioid adenocarcinoma, 6 rectum adenocarcinoma, 6 colon adenocarcinoma, 2 esophagus squamous cell carcinoma, 2 stomach carcinoma, 2 pancreas adenocarcinoma, 2 lung carcinoma, single core per case

Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

BR20824 row: 13; column: 16; cores: 208; cases: 104
EUR 474
Description: Breast tumor tissue microarray (slide 18 of 2600 cases of breast cancer survey slide set), containing 83 cases of invasive carcinoma of no special type, 4 mucinous carcinoma, 9 medullary carcinoma, 6 invasive lobular carcinoma, 1 each of apocrine carcinoma and cystosarcoma phyllodes, duplicate cores per case

Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores

BRC051 row: 1; column: 5; cores: 5; cases: 5
EUR 42
Description: Breast invasive carcinoma of no special type microarray, containing 4 casee of breast invasive carcinoma of no special type and 1 normal breast tissue, single core per case

anti- Human IgA antibody

FNab04075 100µg
EUR 702
Description: Antibody raised against Human IgA

anti- Human IgA antibody

FNab04076 100µg
EUR 702
Description: Antibody raised against Human IgA

Human AMA IgA(Anti-Myelin antibody IgA) ELISA Kit

EH2620 96T
EUR 628.92
Description: Method of detection: Sandwich ELISA, Double Antigen;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Mouse ACA-IgA(anti-Cardiolipin Antibody IgA) ELISA Kit

EM0270 96T
EUR 628.92
Description: Method of detection: Sandwich ELISA, Double Antigen;Reacts with: Mus ;Sensitivity: 0.188 ng/ml

Human β2-GP1 Ab IgA(β2-Glycoprotein 1 antibody IgA) ELISA Kit

EH3984 96T
EUR 628.92
Description: Method of detection: Sandwich ELISA, Double Antigen;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores

FMG010 row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Breast invasive carcinoma of no special type tissue microarray, containing 10 cases of breast invasive carcinoma of no special type, single cores per case

Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a

BR1201b row: 10; column: 12; cores: 120; cases: 60
EUR 354
Description: Breast carcinoma tissue microarray (most of triple negative), containing 56 cases invasive carcinoma of no special type, 2 cases invasive papillary adenocarcinoma, 1 each of medullary carcinoma and apocrine carcinoma, duplicate core per case

Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores

BR1510 row: 10; column: 15; cores: 150; cases: 50
EUR 354
Description: Breast carcinoma tissue microarray, containing 45 cases of invasive carcinoma of no special type, 2 medullary carcinoma, 1 each of metaplastic carcinoma, mixed carcinoma and apocrine carcinoma, triplicate cores per case

Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d

FMG08013e row: 8; column: 9; cores: 72; cases: 72
EUR 168
Description: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case

Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b

HER2c row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case